Experimental cancer drug study halted early

NCT ID NCT04800822

Terminated Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new drug called PF-07284892, alone or with other medicines, in people with advanced solid tumors that had specific genetic changes. The goal was to find the safest dose and check for side effects. The study was stopped early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER WITH BRAF V600E MUTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm hereditary sensory and autonomic neuropathy neurofibromatosis type 1 non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Locations

Brigitte Harris Cancer Pavilion

Detroit, Michigan, 48202, United States
Henry Ford Hospital

Detroit, Michigan, 48202, United States
Henry Ford Medical Center - Columbus

Novi, Michigan, 48377, United States
Mayo Clinic

Scottsdale, Arizona, 85259, United States
Mayo Clinic in Arizona - Phoenix

Phoenix, Arizona, 85054, United States
Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care

New York, New York, 10021, United States
Memorial Sloan Kettering Cancer Center Rockefeller Outpatient Pavilion

New York, New York, 10022, United States
SCRI Oncology Partners

Nashville, Tennessee, 37203, United States
START Midwest

Grand Rapids, Michigan, 49546, United States
Tennessee Oncology PLLC

Franklin, Tennessee, 37067, United States
The University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.